Biostage (BSTG) Stock Price, News & Analysis

Company Overview

Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company's pipeline includes organ-regeneration technology for the repair or replacement of diseased or damaged organs, as well as product candidates to treat cancer, injury, and birth defects of the bronchus. Its lead product candidate is Biostage Esophageal Implant for the treatment of severe esophageal disease. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.

Key Stats

• Today's Range: $4.45 to $4.45
• 50-Day Range: $4.45 to $4.45
• 52-Week Range: $4.45 to $4.45
• Volume: N/A
• Average Volume: 1,847 shs
• Market Capitalization: $61.77 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BSTG Stock Analysis - Frequently Asked Questions

How have BSTG shares performed this year?

Biostage's stock was trading at $4.45 on January 1st, 2025. Since then, BSTG shares have increased by 0.0% and is now trading at $4.45.
View the best growth stocks for 2025 here.

How were Biostage's earnings last quarter?

Biostage, Inc. (OTCMKTS:BSTG) released its quarterly earnings results on Thursday, August, 13th. The company reported ($0.14) earnings per share for the quarter.

How do I buy shares of Biostage?

Shares of BSTG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Biostage own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Biostage investors own include Allena Pharmaceuticals (ALNA), Fulcrum Therapeutics (FULC), Ashford Hospitality Trust (AHT), Assertio (ASRT), Adaptimmune Therapeutics (ADAP), PlayAGS (AGS) and Akebia Therapeutics (AKBA).

Company Calendar

• Last Earnings: 8/13/2020
• Today: 5/18/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:BSTG
• CIK: 1563665
• Web: www.biostage.com
• Phone: (744) 233-7300
• Fax: 774-233-7302
• Employees: 7
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.58)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-6,070,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -174.43%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.73
• Quick Ratio: 2.73

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.26) per share
• Price / Book: -17.12

Miscellaneous

• Outstanding Shares: 13,882,000
• Free Float: 11,758,000
• Market Cap: $61.77 million
• Optionable: Not Optionable
• Beta: -1.02